GlassScriptPhysician profile
Robert Harris Dropkin
NPI 1730198706
$1,836.18
in general payments reported to CMS, 2019-2025
20 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $373 · 2020: $122 · 2021: $44.97 · 2022: $493 · 2023: $521 · 2024: $173 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $702 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $702.36 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $479.35 | 2019-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $277.69 | 2019-2023 | Lo Loestrin Fe |
| Hologic Sales and Service, LLC | $140.52 | 2022-2023 | Aptima |
| Exeltis, USA INC. | $120.98 | 2022-2024 | Slynd, Tyblume |
| Pfizer INC. | $106.15 | 2019-2023 | |
| Myovant Sciences INC. | $87.43 | 2022 | |
| Avion Pharmaceuticals | $82.74 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $73.59 | 2023-2024 | Myfembree |
| Coopersurgical, INC. | $65.61 | 2019-2023 | Endosee |
| Therapeuticsmd, INC. | $63.85 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $58.38 | 2022 | |
| Millicent US INC | $54.90 | 2019-2025 | Femlyv |
| Bayer Healthcare Pharmaceuticals INC. | $49.20 | 2022-2025 | |
| Vertex Pharmaceuticals Incorporated | $39.63 | 2024-2025 | |
| Lupin INC. | $38.45 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $23.96 | 2019 | |
| Ge Healthcare | $21.84 | 2020 | |
| Mylan Pharmaceuticals INC. | $18.23 | 2020 | |
| Merck Sharp & Dohme LLC | $18.02 | 2024 | Gardasil 9, Gardasil |
| Allergan, INC. | $15.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Dropkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.